NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025. Follow the link below to get more information and be contacted by ...

West Pharmaceutical Services (WST) closed the last trading session at $223.77, gaining 2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $284 indicates a 26.9% upside potential.The average comprises 10 short-term price targets ranging from a low of $245 to a high of $355, with a standard deviation of $34.94. While the lowest estimate indicates an increase of 9.5% from the current ...

诉讼案件概述 - Levi & Korsinsky律师事务所针对West Pharmaceutical Services Inc (NYSE: WST)发起证券集体诉讼 [1] - 诉讼旨在为2023年2月16日至2025年2月12日期间因涉嫌证券欺诈遭受损失的投资者追偿损失 [2] 指控内容 - 公司被指控虚假陈述或隐瞒事实：尽管声称对客户需求有清晰可见性并将阻力归因于临时性COVID相关产品去库存化，但实际上其高利润率HVP产品组合正经历持续重大去库存化 [3] - SmartDose设备虽被定位为高利润率增长产品，但因运营效率低下严重稀释公司整体利润率 [3] - 利润率压力导致公司可能退出与长期客户的连续血糖监测合同等成本高昂的重组活动 [3] - 公司关于业务运营和前景的积极陈述因此存在重大虚假或误导性 [3] 诉讼程序 - 受影响投资者需在2025年7月7日前申请成为首席原告 [4] - 集体成员可能无需支付自付费用即可获得赔偿 [4] 律所背景 - Levi & Korsinsky过去20年为受损股东追回数亿美元，拥有70多名员工的团队专门处理复杂证券诉讼 [5] - 连续七年被ISS证券集体诉讼服务评为美国顶级证券诉讼律所之一 [5]

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/west-pharmaceutical-services-inc-loss-submission-form/?id=151935&fr ...

公司诉讼事件 - 西氏医药服务公司(WST)因涉嫌在2023年2月16日至2025年2月12日期间发布重大虚假或误导性声明被集体诉讼 [1] - 指控内容包括隐瞒高利润HVP产品组合持续去库存问题 错误将需求疲软归因于临时性COVID相关因素 [1] - 公司宣称的高增长产品SmartDose设备因运营效率低下严重稀释利润率 并导致退出长期客户的血糖监测合约 [1] 法律程序时间节点 - 股东参与集体诉讼的截止日期为2025年7月7日 需通过指定链接登记损失 [2] - 登记股东将获得案件进展监控服务 无需承担参与诉讼的费用 [2] 律所背景 - Gross Law Firm专注于证券集体诉讼 擅长处理企业欺诈导致的投资者损失案件 [3] - 该律所总部位于纽约 通过15 West 38th Street地址及公开联系方式可触达 [4]

NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased West common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fe ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In West To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in West between February 16, 2023, and February 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, June 6, 2025 /PRNewswire/ -- Faruqi & Faruqi, ...

NEW YORK, June 6, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025. Follow the link below to get more information and be contacted by a memb ...

West Pharmaceutical Services, Inc. Eric M. Green President, CEO and Chair of the Board William Blair 45th Annual Growth Stock Conference June 5, 2025 Safe Harbor Statement Cautionary Statement Under the Private Securities Litigation Reform Act of 1995 This presentation and any accompanying management commentary contain "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about product develop ...

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the July 7, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE:WST) securities during the period from February 16, 2023, through February 12, 2025 (“the Class Period”). [LEARN MORE ABOUT THE CLASS ACTION] On February 13, 2025, when West issued extremely weak 2025 r ...